BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2024 9:30:48 AM | Browse: 260 | Download: 748
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 98872
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biochemistry & Molecular Biology
Manuscript Type Editorial
Article Title Characteristics of gut microbiota dysbiosis in patients with colorectal polyps
Manuscript Source Invited Manuscript
All Author List Xian-Rong Wu, Xiao-Hong He and Yong-Fang Xie
ORCID
Author(s) ORCID Number
Yong-Fang Xie http://orcid.org/0000-0002-8210-5732
Funding Agency and Grant Number
Corresponding Author Yong-Fang Xie, MD, Doctor, Doctor, School of Life Health Informatign Science and Engineering, Chongqing Post and Communications University, No. 2 Chongwen Road, Huangjiao Ya, Nanan District, Chongqing 400065, China. xyf1688@126.com
Key Words Recurrent colorectal polyps; Gut microbiota dysbiosis; Klebsiella; Probiotics; Intestinal inflammation; Microbial intervention strategy
Core Tip This review addresses gut microbiota dysbiosis in patients with recurrent colorectal polyps, noting increased levels of Klebsiella, Parvimonas, and Clostridium and decreased levels of Bifidobacterium and Lactobacillus. This dysbiosis may promote polyp formation and recurrence by creating an inflammatory gut environment. A reduction in probiotics weakens intestinal barrier function, while an increase in pathogens further degrades the gut through their metabolic products and toxins. These changes are also observed in colorectal cancer, inflammatory bowel disease, autism spectrum disorder, and metabolic syndrome. Regulating the gut microbiota, particularly by increasing the use of probiotics, may restore gut health and prevent polyp recurrence. Future research should explore specific mechanisms and evaluate long-term effects.
Publish Date 2024-12-12 09:30
Citation

Wu XR, He XH, Xie YF. Characteristics of gut microbiota dysbiosis in patients with colorectal polyps. World J Gastrointest Oncol 2025; 17(1): 98872

URL https://www.wjgnet.com/1948-5204/full/v17/i1/98872.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i1.98872
Full Article (PDF) WJGO-17-98872-with-cover.pdf